Qube Research & Technologies (QRT)
EHC icon

Qube Research & Technologies (QRT)’s Encompass Health EHC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.4M Sell
557,885
-281,922
-34% -$29.2M 0.05% 459
2026
Q1 		$81.2M Sell
839,807
-111,895
-12% -$11.5M 0.09% 279
2025
Q4 		$101M Buy
951,702
+258,949
+37% +$30M 0.1% 239
2025
Q3 		$88M Sell
692,753
-90,350
-12% -$10.8M 0.09% 269
2025
Q2 		$96M Buy
783,103
+251,037
+47% +$28.7M 0.1% 263
2025
Q1 		$53.9M Sell
532,066
-128,543
-19% -$12.6M 0.06% 380
2024
Q4 		$61M Buy
660,609
+380,840
+136% +$37.4M 0.08% 317
2024
Q3 		$27M Sell
279,769
-9,418
-3% -$846K 0.04% 542
2024
Q2 		$24.8M Sell
289,187
-78,553
-21% -$6.59M 0.04% 537
2024
Q1 		$30.4M Sell
367,740
-210,243
-36% -$15.4M 0.05% 442
2023
Q4 		$38.6M Buy
577,983
+391,509
+210% +$25.4M 0.08% 320
2023
Q3 		$12.5M Buy
186,474
+28,474
+18% +$1.96M 0.03% 554
2023
Q2 		$10.7M Sell
158,000
-84,440
-35% -$5.29M 0.04% 519
2023
Q1 		$13.1M Buy
+242,440
New +$14.1M 0.06% 386
2021
Q4 		– Sell
-77,259
Closed -$4.61M – 2628
2021
Q3 		$4.61M Sell
77,259
-126,103
-62% -$7.93M 0.06% 436
2021
Q2 		$12.6M Buy
+203,362
New +$13.6M 0.14% 160
2021
Q1 		– Sell
-32,996
Closed -$2.17M – 2026
2020
Q4 		$2.17M Buy
+32,996
New +$1.94M 0.03% 587
2020
Q3 		– Sell
-190,022
Closed -$9.36M – 1777
2020
Q2 		$9.36M Buy
+190,022
New +$10.3M 0.14% 182
2020
Q1 		– Sell
-47,977
Closed -$2.64M – 1254
2019
Q4 		$2.64M Buy
+47,977
New +$2.6M 0.08% 287
2019
Q3 		– Sell
-4,917
Closed -$248K – 302
2019
Q2 		$248K Buy
+4,917
New +$239K 0.06% 309
2018
Q4 		– Sell
-5,279
Closed -$327K – 472
2018
Q3 		$327K Buy
5,279
+4,022
+320% +$245K 0.04% 326
2018
Q2 		$68K Buy
+1,257
New +$62.8K 0.04% 408

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EHC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Encompass Health (EHC) stake by 34% in Q2 2026, selling an estimated $29.2M and leaving 557,885 shares worth $56.4M. The position accounts for 0.05% of the portfolio, ranked #459.

Qube Research & Technologies (QRT) first reported a position in EHC in Q2 2018 and has held it in 22 quarters since. The position peaked at $101M in Q4 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 557,885 shares of Encompass Health worth $56.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 281,922 Encompass Health shares in Q2 2026, an estimated $29.2M.
  • Encompass Health made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #459 holding.
  • Qube Research & Technologies (QRT) first reported a position in Encompass Health in Q2 2018 and has held it in 22 quarters since.
  • Qube Research & Technologies (QRT)'s Encompass Health position peaked at $101M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.